Contact this trialFirst, we need to learn more about you.
HDAC Inhibitor
Entinostat + ZEN003694 for Cancer
Recruiting1 awardPhase 1 & 2
New Haven, Connecticut
This trial is testing a combination of two drugs, entinostat and ZEN003694, to see if they are safe and effective in treating patients with advanced or refractory solid tumors or lymphoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.